SMMT insider filings
Summit Therapeutics Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-20. Screen SMMT transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 6 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% owner | 2 | — | — | 4 |
| Zanganeh Mahkam — Co-Chief Executive Officer, Director, 10% owner | 2 | — | — | 4 |
| Soni Manmeet Singh — COO and CFO, Director | 1 | — | — | 2 |
| Anand Bhaskar — Chief Accounting Officer | 1 | — | — | 1 |
Recent insider filings — Summit Therapeutics Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-20 | 4 | DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% owner | Option exercise (M): 300,000 @ $1.06 · Option exercise (M): 300,000 (derivative) @ $0 | EDGAR |
| 2026-11-20 | 4 | Zanganeh Mahkam — Co-Chief Executive Officer, Director, 10% owner | Option exercise (M): 300,000 @ $1.06 · Option exercise (M): 300,000 (derivative) @ $0 | EDGAR |
| 2026-11-16 | 4 | Zanganeh Mahkam — Co-Chief Executive Officer, Director, 10% owner | Option exercise (M): 500,000 @ $1.06 · Option exercise (M): 500,000 (derivative) @ $0 | EDGAR |
| 2026-11-16 | 4 | DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% owner | Option exercise (M): 500,000 @ $1.06 · Option exercise (M): 500,000 (derivative) @ $0 | EDGAR |
| 2026-11-16 | 4 | Soni Manmeet Singh — COO and CFO, Director | Option exercise (M): 100,000 @ $1.37 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2026-10-14 | 4 | Anand Bhaskar — Chief Accounting Officer | Grant/award (A): 100,000 @ $0 | EDGAR |
| 2026-06-12 | 4 | Zanganeh Mahkam — Co-Chief Executive Officer, Director, 10% owner | Purchase (P): 3,810,000 @ $13.12 | EDGAR |
| 2026-06-12 | 4 | DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% owner | Purchase (P): 3,810,000 @ $13.12 | EDGAR |
| 2026-06-04 | 4 | Soni Manmeet Singh — COO and CFO, Director | Purchase (P): 25,000 @ $14.46 · Purchase (P): 25,000 @ $14.43 | EDGAR |
| 2026-06-04 | 4 | Zanganeh Mahkam — Co-Chief Executive Officer, Director, 10% owner | Purchase (P): 100,000 @ $14.60 | EDGAR |
| 2026-06-04 | 4 | DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% owner | Purchase (P): 100,000 @ $14.60 | EDGAR |
| 2026-01-12 | 4 | Anand Bhaskar — Chief Accounting Officer | Grant/award (A): 30,000 (derivative) | EDGAR |
| 2026-01-06 | 4 | Xia Yu — Director | Grant/award (A): 35,000 (derivative) | EDGAR |
| 2026-01-06 | 4 | Cesano Alessandra — Director | Grant/award (A): 35,000 (derivative) · Grant/award (A): 3,219 (derivative) @ $8.76 | EDGAR |
| 2026-01-06 | 4 | Clark Kenneth A — Director | Grant/award (A): 35,000 (derivative) · Grant/award (A): 17,796 (derivative) @ $8.76 | EDGAR |
| 2026-01-06 | 4 | Zanganeh Mahkam — Co-Chief Executive Officer, Director, 10% owner | Grant/award (A): 11,232 (derivative) @ $8.76 | EDGAR |
| 2026-01-06 | 4 | Booth Robert F. — Director | Grant/award (A): 35,000 (derivative) · Grant/award (A): 7,180 (derivative) @ $8.76 | EDGAR |
| 2026-01-06 | 4 | Huber Jeff — Director | Grant/award (A): 35,000 (derivative) · Grant/award (A): 9,885 (derivative) @ $8.76 | EDGAR |
| 2026-01-06 | 4 | Ronaghi Mostafa — Director | Grant/award (A): 35,000 (derivative) | EDGAR |
| 2026-01-06 | 4 | DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% owner | Grant/award (A): 11,232 (derivative) @ $8.76 | EDGAR |
| 2025-10-23 | 4 | Xia Yu — Director | Purchase (P): 533,617 @ $18.74 | EDGAR |
| 2025-10-23 | 4 | Anand Bhaskar — Chief Accounting Officer | Grant/award (A): 26,680 @ $18.74 | EDGAR |
| 2025-10-23 | 4 | Soni Manmeet Singh — COO and CFO, Director | Grant/award (A): 53,361 @ $18.74 | EDGAR |
| 2025-10-23 | 4 | Zanganeh Mahkam — Co-Chief Executive Officer, Director, 10% owner | Grant/award (A): 266,808 @ $18.74 · Purchase (P): 26,680 @ $18.74 · Grant/award (A): 13,980,789 @ $18.74 | EDGAR |
| 2025-10-23 | 4 | DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% owner | Grant/award (A): 13,980,789 @ $18.74 · Grant/award (A): 266,808 @ $18.74 · Purchase (P): 26,680 @ $18.74 | EDGAR |
| 2025-09-19 | 4 | Anand Bhaskar — Chief Accounting Officer | Grant/award (A): 50,000 (derivative) | EDGAR |
| 2025-09-11 | 4 | Zanganeh Mahkam — Co-Chief Executive Officer, Director, 10% owner | Purchase (P): 333,394 @ $17.68 · Purchase (P): 5,000 @ $18.07 | EDGAR |
| 2025-09-11 | 4 | DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% owner | Purchase (P): 333,394 @ $17.68 · Purchase (P): 5,000 @ $18.07 | EDGAR |
| 2025-06-02 | 4 | Zanganeh Mahkam — Co-Chief Executive Officer, Director, 10% owner | Option exercise (M): 74,545 @ $2.64 · Option exercise (M): 74,545 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% owner | Option exercise (M): 74,545 @ $2.64 · Option exercise (M): 74,545 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | Anand Bhaskar — Chief Accounting Officer | Grant/award (A): 600,000 (derivative) · Grant/award (A): 75,000 (derivative) | EDGAR |
| 2025-05-01 | 4 | Soni Manmeet Singh — COO and CFO, Director | Grant/award (A): 11,200,000 (derivative) | EDGAR |
| 2025-05-01 | 4 | Zanganeh Mahkam — Co-Chief Executive Officer, Director, 10% owner | Grant/award (A): 1,040,000 (derivative) · Grant/award (A): 400,000 (derivative) · Grant/award (A): 9,590,558 (derivative) | EDGAR |
| 2025-05-01 | 4 | DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% owner | Grant/award (A): 1,040,000 (derivative) · Grant/award (A): 400,000 (derivative) · Grant/award (A): 9,590,558 (derivative) | EDGAR |
| 2025-04-09 | 4 | Zanganeh Mahkam — Co-Chief Executive Officer, Director, 10% owner | Option exercise/expiry (X): 3,985,055 @ $1.58 · Option exercise/expiry (X): 3,985,055 (derivative) @ $0 | EDGAR |
| 2025-04-09 | 4 | DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% owner | Option exercise/expiry (X): 3,985,055 @ $1.58 · Option exercise/expiry (X): 3,985,055 (derivative) @ $0 | EDGAR |
| 2025-01-14 | 4 | Anand Bhaskar — Chief Accounting Officer | Grant/award (A): 75,000 (derivative) | EDGAR |
| 2025-01-06 | 4 | Xia Yu — Director | Grant/award (A): 35,000 (derivative) · Grant/award (A): 5,438 (derivative) @ $9.18 | EDGAR |
| 2025-01-06 | 4 | Cesano Alessandra — Director | Grant/award (A): 35,000 (derivative) · Grant/award (A): 3,073 (derivative) @ $9.18 | EDGAR |
| 2025-01-06 | 4 | Clark Kenneth A — Director | Grant/award (A): 35,000 (derivative) · Grant/award (A): 16,991 (derivative) @ $9.18 | EDGAR |
| 2025-01-06 | 4 | Zanganeh Mahkam — Co-Chief Executive Officer, Director, 10% owner | Grant/award (A): 10,724 (derivative) @ $9.18 | EDGAR |
| 2025-01-06 | 4 | Huber Jeff — Director | Grant/award (A): 35,000 (derivative) | EDGAR |
| 2025-01-06 | 4 | DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% owner | Grant/award (A): 10,724 (derivative) @ $9.18 | EDGAR |
| 2024-10-15 | 4 | Clark Kenneth A — Director | Grant/award (A): 200,000 (derivative) | EDGAR |
| 2024-10-03 | 4 | Zanganeh Mahkam — Co-Chief Executive Officer, Director | Option exercise/expiry (X): 315,681 @ $1.58 · Option exercise/expiry (X): 315,681 (derivative) @ $0 | EDGAR |
| 2024-09-13 | 4 | Anand Bhaskar — Chief Accounting Officer | Grant/award (A): 22,026 @ $22.70 | EDGAR |
| 2024-09-13 | 4 | Soni Manmeet Singh — COO and CFO, Director | Grant/award (A): 44,052 @ $22.70 | EDGAR |
| 2024-09-13 | 4 | Zanganeh Mahkam — Co-Chief Executive Officer, Director | Grant/award (A): 44,052 @ $22.70 | EDGAR |
| 2024-09-13 | 4 | Huber Jeff — Director | Grant/award (A): 44,052 @ $22.70 | EDGAR |
| 2024-09-13 | 4 | DUGGAN ROBERT W — Co-Chief Executive Officer, Director, 10% owner | Grant/award (A): 3,325,991 @ $22.70 | EDGAR |
Recent 8-K events — Summit Therapeutics Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-18 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-16 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-04 | 8-K | 2.02 — Results of Operations and Financial Condition 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-04 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-29 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-15 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-14 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-03 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-26 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-05 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=SMMT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs